Carbon Dioxide Gas
NDC Package 55037-402-06

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Carbon Dioxide gases is classified as a

administered via respiratory (inhalation) route. This formulation utilizes a gas delivery system. Marketed by Matheson Tri-gas, Inc., this product is identified by NDC 55037-402 and is authorized under FDA application NDA217082.

Identification & Billing

NDC Package Code
55037-402-06
Package Description
640.64 L in 1 CYLINDER
Product Code
11-Digit Billing Format
55037040206
RxNorm Crosswalk
RxCUI: 347967 - carbon dioxide 99.2 % Gas for Inhalation

Clinical Specifications

Proprietary Name
Carbon Dioxide
Non-Proprietary Name
Carbon Dioxide
Substance Name
Carbon Dioxide
Dosage Form
Gas - Any elastic aeriform fluid in which the molecules are separated from one another and so have free paths.
Administration Route
Respiratory (inhalation) - Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect.
Active Ingredient(s)

Regulatory & Marketing

Labeler Name
Matheson Tri-gas, Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA217082
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
01-01-1987
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (55037-402). Click a package code to view its specific billing and regulatory data.

88.7 L in 1 CYLINDER
246.4 L in 1 CYLINDER
369.6 L in 1 CYLINDER
418.88 L in 1 CYLINDER
517.44 L in 1 CYLINDER
1059.5 L in 1 CYLINDER
1330.5 L in 1 CYLINDER
1453.7 L in 1 CYLINDER
1724.8 L in 1 CYLINDER
2464 L in 1 CYLINDER
3696 L in 1 CYLINDER
3967.04 L in 1 CYLINDER
4928 L in 1 CYLINDER
5790.4 L in 1 CYLINDER
6160 L in 1 CYLINDER
12320 L in 1 CYLINDER
11827 L in 1 CYLINDER
16016 L in 1 CYLINDER
17987.2 L in 1 CYLINDER
24640 L in 1 CYLINDER
616 L in 1 CYLINDER
7392 L in 1 CYLINDER
8624 L in 1 CYLINDER
9856 L in 1 CYLINDER
95800 L in 1 CONTAINER
106670 L in 1 CONTAINER
113610 L in 1 CONTAINER
130680 L in 1 CONTAINER
150250 L in 1 CONTAINER
15520 L in 1 TANK

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55037-402-06 identifies a specific commercial package of 640.64 l in 1 cylinder of Carbon Dioxide, a human prescription drug labeled by Matheson Tri-gas, Inc.. This gas is formulated for respiratory (inhalation) use and contains carbon dioxide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Matheson Tri-gas, Inc. on January 01, 1987. The current certification is valid through December 31, 2026.

How is this Matheson Tri-gas, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55037040206. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
55037-402-06
11-Digit CMS (5-4-2)
55037-0402-06

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.